VEGFR Antibody
Inlecitug is a chimeric monoclonal antibody that targets the human KDR (kinase insert domain receptor) . By specifically binding to KDR, Inlecitug blocks the interaction between vascular endothelial growth factor (VEGF) and KDR, thereby inhibiting angiogenesis and exerting antitumor activity. Inlecitug holds potential for cancer research.
Product Specifications
Target
VEGFR
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cardiovascular Research, Cardiovascular Research; Cell Biology, Signal Transduction
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog